United States: Doctors and health planners in the United States advise persons above the age of 50 to take vaccines for pneumonia and several other diseases. Pneumonia is a specific lung inflammation that may result in shortness of breath, high body temperature, and productive cough indicative of coloring, GREEN or BLOODY sputum production.
In fact, pneumonia can be a fatal condition for the elderly because their bodies’ defense mechanisms weaken as they age. This vaccine assists in preventing diseases from the dangerous bacteria and helps lessen the chance for a more severe condition. Older people should also get vaccinated to remain healthy and prevent severe illnesses that result from pneumonia and other conditions.
The advice, or recommendation, is from a group of scientific advisors and is CDC compliant. The former target group age for adult immunisations was 65 years and over years.
As reported by Health and Lifestyle, CDC Director, Dr. Mandy Cohen stated that, “If you want to be ready for winter respiratory season like the flu, now is a good time to get vaccinated for pneumococcal disease.”
The advisors voted on the change 14 to 1 in an October meeting held in Atlanta, Georgia, headquarters of the CDC. Doctors include the agency’s recommendations in their practice.

BMJ recommendations for pneumococcal shots are sometimes also referred to as the most complex vaccination advice the government provides.
The CDC now advises shots for children below the age of five years and adults with 50 years and above who have not received pneumococcal shots before. Health experts also advise the shots for children and people whose conditions make them particularly susceptible to pneumococcal disease, including diabetics, those with liver disease or a weakened immune or defense system.
These are the four strains which are more than 100 types of pneumococcal bacteria that scientists know exist unknowingly. It can lead to severe illness in the respiratory tracts and the rest of the human body.
How often does the U.S get pneumococcal disease?
This is estimated to occur about 30,000 times every year leading to blood infections, inflammation of the brain or spinal cord and many other complications. About 30 percent of cases are in persons aged 50-64 years.
The earliest pneumococcal immunization was approved in the United States in 1977. Since then pharma companies have been developing new formulations that tackle several bacteria in one throw.
There are four vaccines currently being used. They include Wyeth- Pfizer Prevnar 20 and Merck Vaxneuvance and Pneumovax 23.
Leave a Reply